Lepu Biopharma Co., Ltd. - H Shares Stock: price and insider trades · Hong Kong
1 insider bought €364k of shares over the last 90 days, the latest by Pu Zhongjie, filed 30 Oct 2026.
Lepu Biopharma Co., Ltd. - H Shares: what insiders have been doing
Lepu Biopharma Co., Ltd. - H Shares has a thin disclosure history in our data (latest filing: 30 October 2026). New filings will appear here as soon as they are published. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,050,000 shares@ HK$3.04100.0% of flowShareXHKGHKEX:DA20261030E00224Canonical exit: 25 Jan 2027 (T+90)
1 of 1 declaration
About Lepu Biopharma Co., Ltd. - H Shares
Lepu Biopharma Co., Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the development and commercialization of biopharmaceutical products. It focuses on treatments for cardiovascular diseases and metabolic disorders.